Amador Bioscience completes the acquisition of Ann Arbor Pharmacometrics Group (A2PG) – QNT Press Release

[ad_1]

Pleasanton, California and Ann Arbor, me., December 24, 2021 /PRNewswire/ – Amado Biosciences, Global Translational Science and Clinical Pharmacology CRO, Announced today that it has completed the acquisition of Ann Arbor Pharmacometrics Group (Ann Arbor Pharmacometrics Group)A2PG), A leading pharmacometric consulting company headquartered in Ann Arbor, Michigan.

Amador Bioscience and A2PG will become a one-stop global translational science and clinical pharmacology CRO.

“Amador Bioscience’s mission is to use our rich industry experience, global influence and ecosystem to provide global standard services for the efficient development of new drugs. We are very happy to join forces with the A2PG team to strengthen our global leadership…

The full story can be found on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center